TESTOSTERONE DEFICIENCY AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MEN WITH TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Khripun, Irina A. [1 ]
Vorobyev, Sergey V. [1 ]
Allakhverdieva, Yanina S. [1 ]
机构
[1] Rostov State Med Univ, Rostov Na Donu, Russia
来源
DIABETES MELLITUS | 2019年 / 22卷 / 06期
关键词
hypogonadism; testosterone; diabetes mellitus; nonalcoholic fatty liver disease; liver; androgen deficiency; HYPOGONADISM;
D O I
10.14341/DM10232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Current studies investigated diseases associated with testosterone (T) deficiency; however, data on the combination of non-alcoholic fatty liver disease (NAFLD) with hypogonadism and diabetes mellitus (DM) in men are extremely limited. AIMS: To evaluate the effects of hypogonadism on the formation and progression of NAFLD in men with type 2 DM. METHODS: The study included 90 men with type 2 DM [age 54 (49-57) years]. Patients underwent clinical examinations, biochemical analysis (alanine aminotransferase (ALT), aspartate aminotransferase, gamma-glutamyl transpeptidase (GGTP), fasting glucose, immunoreactive insulin, HOMA index, HbA(1c), lipid profile), immune enzyme analysis (luteinising hormone, total T, sex hormone binding globulin, resistin, adiponectin, leptin) and magnetic resonance imaging with liver fat fraction determination were performed. Patients were divided into two groups: 1-32 eugonadal patients and 2-58 men with newly diagnosed hypogonadism. RESULTS: Increased insulin resistance, hyperinsulinemia, hypertriglyceridemia were observed in men with hypogonadism compared to eugonadal patients. Along with biochemical signs of impaired liver function, such as an increase in liver enzyme concentrations of ALT by 24.5% (p = 0.02), GGTP by 60.5% (p = 0.001), de Rytis coefficient by 60.4% (p = 0.047), of men in the 2nd group, the liver fat fraction also increased, which together indicates NAFLD progression. The proton density of the liver fat fraction according to MRI was 4.12 [2.25-5.30] % in the 1st group and 10.30 [7.78; 14.44] % in the 2nd group (p=0.001). This was accompanied by an increase in fat production of resistin by 2 times and leptin by 12 times (p<0.001) in patients of group 2 compared to 1. CONCLUSIONS: The combination of type 2 DM with hypogonadism in men leads not only to deterioration of carbohydrate and lipid metabolism but also to disturbance of liver function: increased ALT, GGTP concentrations and liver fat. Increased secretion of leptin and resistin in the adipose tissue is assumed to be a pathogenetically associated with the development of carbohydrate and lipid metabolism disorders, NAFLD and T deficiency.
引用
收藏
页码:542 / 549
页数:8
相关论文
共 50 条
  • [31] Non-alcoholic fatty liver disease and risk of type 2 diabetes
    Lallukka, S.
    Yki-Jarvinen, H.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 30 (03) : 385 - 395
  • [32] The Effect of Empagliflozin on Liver Fat in Type 2 Diabetes Mellitus Patients With Non-Alcoholic Fatty Liver Disease
    Pokharel, Arbinda
    Sudhamshu, K. C.
    Thapa, Pukar
    Karki, Niyanta
    Shrestha, Rupesh
    Jaishi, Bikash
    Paudel, Mukesh S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (07)
  • [33] Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma
    Kosmalski, Marcin
    Sliwinska, Agnieszka
    Drzewoski, Jozef
    BIOMEDICINES, 2023, 11 (04)
  • [34] Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
    Petunina, Nina A.
    Telnova, Milena E.
    Goncharova, Ekaterina V.
    Martirosian, Narine S.
    Kuzina, Irina A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (10) : 1155 - 1162
  • [35] Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
    Li, Wei-Dong
    Fu, Kun-Fa
    Li, Gui-Mei
    Lian, Yan-Shu
    Ren, Ai-Min
    Chen, Yun-Jue
    Xia, Jin-Rong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (32) : 9607 - 9613
  • [36] The Effect of Semaglutide on Glycolipid Metabolism in Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
    Ding, Li Ping
    Liu, Shen Kun
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 171 - 175
  • [37] Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus
    Wei-Dong Li
    Kun-Fa Fu
    Gui-Mei Li
    Yan-Shu Lian
    Ai-Min Ren
    Yun-Jue Chen
    Jin-Rong Xia
    World Journal of Gastroenterology, 2015, (32) : 9607 - 9613
  • [38] Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
    Mansour, Asieh
    Motamed, Soudabe
    Hekmatdoost, Azita
    Karimi, Sara
    Mohajeri-Tehrani, Mohammad Reza
    Abdollahi, Mohammad
    Jelodar, Reihane
    Sajjadi-Jazi, Sayed Mahmoud
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [39] Efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease
    Tian, Feng
    Zheng, Zhigang
    Zhang, Damin
    He, Si
    Shen, Jie
    BIOSCIENCE REPORTS, 2018, 38
  • [40] Factors related to hypermetabolism in individuals with type 2 diabetes mellitus and non-alcoholic fatty liver disease
    Asieh Mansour
    Soudabe Motamed
    Azita Hekmatdoost
    Sara Karimi
    Mohammad Reza Mohajeri-Tehrani
    Mohammad Abdollahi
    Reihane Jelodar
    Sayed Mahmoud Sajjadi-Jazi
    Scientific Reports, 13